Yifeng Pharmacy Net Asset Quality Index
Yifeng Pharmacy net asset quality index. Yifeng Pharmacy (603939) has a Net Asset Quality Index of 44.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥26.07 Billion minus total liabilities of CN¥14.41 Billion yields net assets of CN¥11.66 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 603939 net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Yifeng Pharmacy (2011–2024)
Net asset quality index of Yifeng Pharmacy from 2011 to 2024. This chart shows how Yifeng Pharmacy's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 44.7%, representing net assets of CN¥11.66 Billion against total assets of CN¥26.07 Billion CNY. Check 603939 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Yifeng Pharmacy Net Asset Quality Index by Year (2011–2024)
Yifeng Pharmacy net asset quality index by year from 2011 to 2024. The table below presents the year-by-year Net Asset Quality Index for Yifeng Pharmacy from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Yifeng Pharmacy market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 40.7% | CN¥11.39 Billion | CN¥27.97 Billion | CN¥16.58 Billion | ▼ -2.6 pp |
| 2023 | 43.3% | CN¥10.45 Billion | CN¥24.14 Billion | CN¥13.69 Billion | ▼ -0.1 pp |
| 2022 | 43.4% | CN¥9.12 Billion | CN¥21.04 Billion | CN¥11.92 Billion | ▼ -2.8 pp |
| 2021 | 46.1% | CN¥7.86 Billion | CN¥17.05 Billion | CN¥9.19 Billion | ▲ +1.5 pp |
| 2020 | 44.6% | CN¥5.78 Billion | CN¥12.95 Billion | CN¥7.17 Billion | ▼ -6.7 pp |
| 2019 | 51.3% | CN¥4.71 Billion | CN¥9.18 Billion | CN¥4.47 Billion | ▼ -1.7 pp |
| 2018 | 53.0% | CN¥4.17 Billion | CN¥7.87 Billion | CN¥3.70 Billion | ▼ -13.5 pp |
| 2017 | 66.5% | CN¥3.18 Billion | CN¥4.78 Billion | CN¥1.60 Billion | ▼ -4.0 pp |
| 2016 | 70.5% | CN¥2.98 Billion | CN¥4.22 Billion | CN¥1.25 Billion | ▲ +12.2 pp |
| 2015 | 58.3% | CN¥1.42 Billion | CN¥2.44 Billion | CN¥1.02 Billion | ▲ +10.6 pp |
| 2014 | 47.6% | CN¥595.76 Million | CN¥1.25 Billion | CN¥655.19 Million | ▼ -1.3 pp |
| 2013 | 48.9% | CN¥502.20 Million | CN¥1.03 Billion | CN¥524.21 Million | ▼ -1.4 pp |
| 2012 | 50.4% | CN¥425.82 Million | CN¥845.45 Million | CN¥419.63 Million | ▲ +8.1 pp |
| 2011 | 42.2% | CN¥356.28 Million | CN¥843.41 Million | CN¥487.12 Million | — |